Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease

Completed · Phase 1

Conditions studied: Alzheimer's Disease, Healthy

In brief

The purpose of this study is to assess the bioavailability of four experimental formulations relative to the current reference formulation used in the Phase 2 study.

Key facts

Study ID

NCT00901498

Run by

Bristol-Myers Squibb

People needed

36

Starts

2009-05-01

Expected to finish

2009-07-01

Last updated by the study team

2011-01-07

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Young healthy male subjects

You may not qualify if…

• Women

Where it is running

• Mds Pharma Services (Us) Inc. — Neptune City, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.